Short Interest in Mesoblast Limited (OTCMKTS:MEOBF) Increases By 18.3%

Mesoblast Limited (OTCMKTS:MEOBF) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 32,761,000 shares, a growth of 18.3% from the March 15th total of 27,682,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Mesoblast Stock Performance

Shares of MEOBF opened at $1.50 on Tuesday. Mesoblast has a 1 year low of $0.55 and a 1 year high of $5.34. The stock’s 50-day moving average price is $1.76 and its two-hundred day moving average price is $1.58.

About Mesoblast

Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.